Riik: Hispaania
keel: inglise
Allikas: HMA (Heads of Medicines Agencies)
marbofloxacin 20 mg/ml
Miklich Laboratorios S.L
QJ01MA93
Solution for injection
marbofloxacin
Cattle, Pigs
2011-03-23
Revised: January 2013 AN: 01322/2012 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Quiflor 20 mg/ml Solution for Injection for Cattle and Pigs 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of solution for injection contains: ACTIVE SUBSTANCE: Marbofloxacin 20 mg EXCIPIENTS: Metacresol 2 mg Disodium edetate 0.10 mg Monothioglycerol 0.50 mg For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for injection. Clear, greenish yellow to brownish yellow solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (pre-ruminant calves up to 100 kg b.w). Pigs. 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES CATTLE (PRE-RUMINANT CALVES UP TO 100 KG B.W) Treatment of respiratory infections caused by sensitive strains of _Pasteurella _ _multocida, Mannheimia haemolytica _and_ Mycoplasma bovis. _ _ _ FATTENING PIGS Treatment of respiratory infections caused by sensitive strains of _Actinobacillus _ _pleuropneumoniae, Mycoplasma hyopneumoniae, Pasteurella multocida. _ _ _ The veterinary medicinal product should only be used based on susceptibility testing. 4.3 CONTRAINDICATIONS Do not administer in animals with known hypersensitivity to marbofloxacin or any other quinolone or to any of the excipients. Revised: January 2013 AN: 01322/2012 Page 2 of 5 Do not use in cases where the pathogen involved is resistant to other fluoroquinolones (cross resistance). 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE i. Special Lugege kogu dokumenti